EAST HANOVER, N.J., April 11 /PRNewswire/ -- New data show that a once-yearly infusion of Reclast(R) (zoledronic acid) Injection 5mg was significantly better than risedronate at increasing bone mass ...

Reclast (zoledronic acid or zoledronate) is approved by the Food and Drug Administration (FDA) to treat and prevent osteoporosis in males, females after menopause, and people taking glucocorticoids.

Zoledronic acid 5 mg/100 mL bottle; solution for IV infusion. Paget’s disease of bone is characterized by greatly increased and disorderly bone remodeling. Excessive osteoclastic bone resorption is ...

As with all medications, the cost of zoledronic acid can vary. Factors that may affect the price you’ll pay include your treatment plan and your insurance coverage. It may also depend on the cost of ...

Dear Dr. Roach: I have osteoporosis. My mother had it very badly, so I was screened and treated early. I’ve had a five-year-long Reclast prescription, and I worry about my chance of a femur fracture.